ZAI LAB LIMITED Shares Outstanding
ZAI LAB LIMITED (ZLAB) had Shares Outstanding of 1.12 billion shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-06
- 2026-06-30: Shares outstanding (split-adjusted) 1.12B shares; Shares authorized (split-adjusted) 5.00B shares.
- 2026-03-31: Shares outstanding (split-adjusted) 1.11B shares; Shares authorized (split-adjusted) 5.00B shares.
- 2025-12-31: Shares outstanding (split-adjusted) 1.11B shares; Shares authorized (split-adjusted) 5.00B shares.
- 2025-09-30: Shares outstanding (split-adjusted) 1.11B shares; Shares authorized (split-adjusted) 5.00B shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 1.12B shares 10-Q · filed 2026-08-06 | 5.00B shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 1.11B shares 10-Q · filed 2026-05-07 | 5.00B shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 1.11B shares 10-Q · filed 2026-08-06 | 5.00B shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 1.11B shares 10-Q · filed 2025-11-06 | 5.00B shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 1.10B shares 10-Q · filed 2025-08-07 | 5.00B shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 1.08B shares 10-Q · filed 2025-05-08 | 5.00B shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 1.08B shares 10-K · filed 2026-02-26 | 5.00B shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 984.36M shares 10-Q · filed 2024-11-12 | 5.00B shares 10-Q · filed 2024-11-12 |
| 2024-06-30 | 981.40M shares 10-Q · filed 2024-08-06 | 5.00B shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 973.29M shares 10-Q · filed 2024-05-08 | 5.00B shares 10-Q · filed 2024-05-08 |
| 2023-12-31 | 972.24M shares 10-K · filed 2025-02-27 | 5.00B shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 969.04M shares 10-Q · filed 2023-11-07 | 5.00B shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 968.57M shares 10-Q · filed 2023-08-07 | 5.00B shares 10-Q · filed 2023-08-07 |
| 2023-03-31 | 963.69M shares 10-Q · filed 2023-05-09 | 5.00B shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 960.22M shares 10-K · filed 2024-02-27 | 5.00B shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 959.72M shares 10-Q · filed 2022-11-09 | 5.00B shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 958.49M shares 10-Q · filed 2022-08-09 | 5.00B shares 10-Q · filed 2022-08-09 |
| 2022-03-31 | 956.64M shares 10-Q · filed 2022-05-10 | 5.00B shares 10-Q · filed 2022-05-10 |
| 2022-03-30 | (m) | 5.00B shares 10-K · filed 2024-02-27 |
| 2021-12-31 | 954.98M shares 10-K · filed 2023-03-01 | 5.00B shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 95.27M shares 10-Q · filed 2021-11-09 | 500.00M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 94.76M shares 10-Q · filed 2021-08-09 | 500.00M shares 10-Q · filed 2021-08-09 |
| 2021-03-31 | 88.52M shares 10-Q · filed 2021-05-10 | 500.00M shares 10-Q · filed 2021-05-10 |
| 2020-12-31 | 87.81M shares 10-K · filed 2022-03-01 | 500.00M shares 10-K · filed 2022-03-01 |
| 2020-06-30 | 74.88M shares 6-K · filed 2020-09-11 | 83.33M shares 6-K · filed 2020-09-11 |
| 2019-12-31 | 68.24M shares 10-K · filed 2021-03-01 | 500.00M shares 10-K · filed 2021-03-01 |
| 2019-09-30 | 67.75M shares 6-K · filed 2020-01-21 | 83.33M shares 6-K · filed 2020-01-21 |
| 2018-12-31 | 58.01M shares 20-F · filed 2020-04-29 | 83.33M shares 20-F · filed 2020-04-29 |
| 2017-12-31 | 49.91M shares 20-F · filed 2019-03-29 | 83.33M shares 20-F · filed 2019-03-29 |
| 2016-12-31 | 9.66M shares 20-F · filed 2018-04-30 | 83.33M shares 20-F · filed 2018-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |